Abstract:Objective To investigate the influence of postoperative transcatheter arterial chemoembo-lization (TACE) on the survival time and prognosis in hepatocellular carcinoma (HCC) patients after liver resection. Methods During the period from January 2008 to November 2012, a total of 92 patients with HCC were admitted to authors’ hospital, and all the patients received TACE after liver resection. The clinical data were retrospectively analyzed. Those patients who showed no lesions on imaging examination within two months after the surgery were classified in prevention group (n=38) and prophylactic TACE was carried out after the surgery. Those patients who did not receive TACE until recurrence was detected on imaging examination were regarded as control group (n = 54). The difference in the survival time between the two groups was analyzed by using Kaplan Meier method, while the related factors influencing postoperative survival time and prognosis were analyzed by using COX regression method. Results No statistically significant difference in the baseline data existed between the two groups. The one-year, 2-year and 3-year survival rates of all the patients were 71%, 48% and 41% respectively, with a median survival time of 24.1 months. For the prevention group, the one-year, 2-year and 3-year survival rates were 85.1%, 56.8% and 56.8% respectively, with a median survival time of 39 months. For the control group, the one-year, 2-year and 3-year survival rates were 65.2%, 43.4% and 30.4% respectively, with a median survival time of 21 months. The difference in the cumulated survival rate between the two groups was statistically significant(P = 0.021). Both the single factor analysis and multifactor analysis showed that, like tumor thrombus in portal vein, tumor diameter, ascites, prothrombin time, etc. the use of postoperative prophylactic TACE was a related factor that could significantly influence the postoperative survival time and prognosis. Conclusion The use of postoperative prophylactic TACE can obviously improve the survival rate of liver cancer patients. The tumor diameter is also an independent factor that can significantly affect the prognosis.(J Intervent Radiol, 2014, 23:299-302).

Oxidative stress in livertissues in HCC patients after TACE

Preliminary Study of Oxidative Stress in Human Hepatocellular Carcinoma and Adjacent Normal Liver Tissues

Preoperative Transcatheter Arterial Chemotherapy May Suppress Oxidative Stress in Hepatocellular Carcinoma Cells and Reduce the Risk of Short-Term Relapse

Changes in Immunological Function after Treatment with Transarterial Chemoembolization Plus Radiofrequency Ablation in Hepatocellular Carcinoma Patients

Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection

Effects of Transcatheter Arterial Chemoembolization (TACE) Combined with Cryoablation on Immunologic Function in Patients with Advanced Primary Hepatocellular Carcinoma

Expression of p53 Protein of Hepatocellular Carcinoma Cells after Transcatheter Arterial Chemoembolization

Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma

Changes of CD4+ CD25+ Regulatory T Cells in Peripheral Blood in Patients with Hepatocellular Carcinoma Before and after TACE

Effect of Transcatheter Arterial Chemoembolization on Cellular Immune Function and Regulatory T Cells in Patients with Hepatocellular Carcinoma.

The Role of Oxidative Stress in the Development and Therapeutic Intervention of Hepatocellular Carcinoma

Relationship between TIGIT expression on T cells and the prognosis of patients with hepatocellular carcinoma

The Effect of Regulatory T Cells Level in Peripheral Blood on the Prognosis in HCC Patients after TACE

Advances in Study on Oxidative Stress in Hepatocellular Carcinoma

The influence of postoperative TACE on the survival time and prognosis in hepatocellular carcinoma patients after liver resection

An Oxidative Stress-Related Prognostic Signature Predicts Treatment Response and Outcomes for Hepatocellular Carcinoma after Transarterial Chemoembolization

Expression of PCNA and Nm23-H1/ndpk in Hepatocellular Carcinoma Following Transcatheter Arterial Chemoembolization Therapy

Expression of Foxp3 mRNA in hepatocellular carcinoma peripheral blood and effect of TACE on its expression

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study

Randomized Controlled Study of CT Perfusion Imaging in Patients with Hepatocellular Carcinoma Before and After Transarterial Infusion of Endostar Combined with Chemoembolization

Clinical Study of Advanced Primary Hepatocellular Carcinoma Cells after TACE with Use of Portal Vein Perfusion Chemothepary